Chemoprevention in breast cancer and possible vaccine for prostate cancer
Chemoprevention in breast cancer and possible vaccine for prostate cancer
Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder
The impact of microbiota on the immune response
Preventing the preventable
“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment
High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients
ENDEAVOR: carfilzomib new standard in multiple myeloma?
How can functional drug screening guide personalised cancer therapy?
How do genes influence the development of chronic idiopathic thrombocytopenic purpura?
Combining treatment options for higher risk myelodysplastic syndromes and chronic myelomonocytic leukaemia
ASH 2015: Highlights in mantle cell lymphoma
Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia